The ECB's economists will provide new forecasts Thursday, as they do every quarter. Those will be the first to take account of the Trump administration's 25% tariff on imports of steel, aluminum and ...

The deal includes a drug for systemic mastocytosis, a rare immunology disease, approved in the U.S. and the European Union under the brand names Ayvakit and Ayvakyt as well as an early-stage ...